組織検査の世界市場:免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法

◆英語タイトル:Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020
◆商品コード:MAM-MD-2349
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2015年12月2日
◆ページ数:176
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥570,650見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥671,650見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥823,150見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、組織検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、疾病別分析、製品別分析、需要先別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. However, the high growth potential in emerging economies and the increased use of personalized medicine will provide new growth opportunities to players in the market.

This report segments the global market based on product, technology, disease, and end user. On the basis of product, the market is segmented into instruments and consumables. In 2015, consumables are expected to account for the largest share of the global market, by product, due to their low cost and ease of use.

On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. In 2015, the immunohistochemistry segment is expected to account for the largest share of the global market. The technology is mainly driven by growth in the IVD (in vitro diagnostics) market.

On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. In 2015, the breast cancer segment is expected to account for the largest share of the global market. The growth of this segment is driven by the increasing incidence of breast cancer.

On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users. In 2015, the hospitals segment is expected to account for the largest share of the global market. This large share is attributed to the easy accessibility and availability of test results in hospitals in a shorter period of time.

On the basis of region, the tissue diagnostics market is segmented into Asia, Europe, North America, and the Rest of the World (RoW). In 2015, North America is expected to command the largest share of the global market.

The major players in tissue diagnostics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), BioGenex Laboratories (U.S.), Bio SB (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), F. Hoffman-La Roche AG (Switzerland), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Sakura Finetek Japan Co.

【レポートの目次】

1 Introduction (Page No. – 10)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 13)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 20)

4 Premium Insights (Page No. – 25)
4.1 Global Tissues Diagnostics Market Overview
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 28)
5.1 Introduction
5.1.1 By Disease
5.1.2 By End User
5.1.3 By Product
5.1.4 By Technology
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidences of Cancer
5.2.1.2 Rapidly Increasing Aging Population
5.2.1.3 Growing Healthcare Expenditure
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Requirements and Compliance
5.2.2.2 High Degree of Consolidation
5.2.2.3 Budget Constraints
5.2.3 Opportunities
5.2.3.1 High Growth in Emerging Markets
5.2.3.2 Increased Use of Personalized Medicine
5.2.4 Trends
5.2.4.1 Increasing Number of Reagent Rental Agreements

6 Tissue Diagnostics Market, By Product (Page No. – 37)
6.1 Introduction
6.2 Consumables
6.2.1 Antibodies
6.2.2 Kits
6.2.3 Reagents
6.2.4 Probes
6.3 Instruments
6.3.1 Slide-Staining Systems
6.3.2 Scanners
6.3.3 Tissue-Processing Systems
6.3.4 Other Instruments

7 Tissue Diagnostics Market, By Diseases (Page No. – 54)
7.1 Introduction
7.2 Breast Cancer
7.3 Gastric Cancer
7.4 Lymphoma
7.5 Prostate Cancer
7.6 Non-Small Cell Lung Cancer
7.7 Other Diseases

8 Tissue Diagnostics Market, By Technology (Page No. – 67)
8.1 Introduction
8.2 Immunohistochemistry (IHC)
8.3 in Situ Hybridization (ISH)
8.4 Digital Pathology and Workflow Management
8.5 Special Staining

9 Tissue Diagnostics Market, By End User (Page No. – 76)
9.1 Introduction
9.2 Hospitals
9.3 Research Laboratories
9.4 Pharmaceutical Companies
9.5 Contract Research Organizations
9.6 Other End Users

10 Tissue Diagnostics Market, By Region (Page No. – 85)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 120)
11.1 Introduction
11.2 Strategic Overview
11.3 Leading Players in the Tissue Diagnostics Market
11.4 Competitive Situation and Trends
11.4.1 New Products Launches and Product Upgrades
11.4.2 Acquisitions
11.4.3 Expansions
11.4.4 Agreements, Collaborations, Contracts, Marketing Initiatives, and Partnerships
11.4.5 Other Developments

12 Company Profiles (Page No. – 129)
12.1 Introduction
12.2 Abbott Laboratories, Inc.
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments
12.2.4 MnM View
12.3 Agilent Technologies, Inc.
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments
12.3.4 MnM View
12.4 Bio Sb
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments
12.4.4 MnM View
12.5 Biogenex Laboratories
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Developments
12.5.4 MnM View
12.6 Cell Signaling Technology, Inc.
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments
12.6.4 MnM View
12.7 Danaher Corporation
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments
12.7.4 MnM View
12.8 F. Hoffman-La Roche AG
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Recent Developments
12.8.4 MnM View
12.9 Sakura Finetek Japan Co., Ltd.
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Recent Developments
12.10 Sigma-Aldrich Corporation
12.10.1 Business Overview
12.10.2 Products Offered
12.10.3 Recent Development
12.10.4 MnM View
12.11 Thermo Fisher Scientific
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments
12.11.4 MnM View

13 Appendix (Page No. – 156)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables (76 Tables)

Table 1 Tissue Diagnostics Market Summary
Table 2 Rising Incidences of Cancer are the Primary Driver for the Market
Table 3 Stringent Regulatory Requirements is A Key Restraint for the Growth of the Market
Table 4 Emerging Economies Present Significant Growth Opportunities
Table 5 Increasing Number of Reagent Rental Agreements is A Major Trend for the Growth of This Market
Table 6 Market Size, By Product, 2013–2020 (USD Million)
Table 7 Market Size, By Consumable, 2013–2020 (USD Million)
Table 8 Market Size for Consumables, By Region, 2013–2020 (USD Million)
Table 9 Market Size for Antibodies, By Region, 2013–2020 (USD Million)
Table 10 Market Size for Kits, By Region, 2013–2020 (USD Million)
Table 11 Market Size for Reagents, By Region, 2013–2020 (USD Million)
Table 12 Market Size for Probes, By Region, 2013–2020 (USD Million)
Table 13 Market Size, By Instrument, 2013–2020 (USD Million)
Table 14 Market Size for Instruments, By Region, 2013–2020 (USD Million)
Table 15 Market Size for Slide-Staining Systems, By Region, 2013–2020 (USD Million)
Table 16 Market Size for Scanners, By Region, 2013–2020 (USD Million)
Table 17 Market Size for Tissue-Processing Systems, By Region, 2013–2020 (USD Million)
Table 18 Market Size for Other Instruments, By Region, 2013–2020 (USD Million)
Table 19 Market Size, By Disease, 2013–2020 (USD Million)
Table 20 Market Size for Breast Cancer, By Region, 2013–2020 (USD Million)
Table 21 Market Size for Gastric Cancer, By Region, 2013–2020 (USD Million)
Table 22 Market Size for Lymphoma, By Region, 2013-2020 (USD Million)
Table 23 Market Size for Prostate Cancer, By Region, 2013–2020 (USD Million)
Table 24 Market Size for Non-Small Cell Lung Cancer, By Region, 2013–2020 (USD Million)
Table 25 Market Size for Other Diseases, By Region, 2013–2020 (USD Million)
Table 26 Market Size, By Technology, 2013–2020 (USD Million)
Table 27 Market Size for Immunohistochemistry, By Region, 2013–2020 (USD Million)
Table 28 Market Size for in Situ Hybridization, By Region, 2013–2020 (USD Million)
Table 29 Market Size for Digital Pathology and Workflow Management, By Region, 2013-2020 (USD Million)
Table 30 Market Size for Special Staining, By Region, 2013–2020 (USD Million)
Table 31 Market Size, By End User, 2013–2020 (USD Million)
Table 32 Market Size for Hospitals, By Region, 2013–2020 (USD Million)
Table 33 Market Size for Research Laboratories, By Region, 2013–2020 (USD Million)
Table 34 Market Size for Pharmaceutical Companies, By Region, 2013-2020 (USD Million)
Table 35 Market Size for Contract Research Organizations, By Region, 2013–2020 (USD Million)
Table 36 Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 37 Market Size, By Region, 2013–2020 (USD Million)
Table 38 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 39 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 40 North America: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 41 North America: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 42 North America: Market Size, By Disease, 2013–2020 (USD Million)
Table 43 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 44 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 45 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 46 U.S.: Market Size, By Disease, 2013–2020 (USD Million)
Table 47 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 48 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 49 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 50 Canada: Market Size, By Disease, 2013–2020 (USD Million)
Table 51 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 52 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 53 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 54 Europe: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 55 Europe: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 56 Europe: Market Size, By Disease, 2013–2020 (USD Million)
Table 57 Europe: Market Size, By Technology, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 59 Asia: Market Size, By Product, 2013–2020 (USD Million)
Table 60 Asia: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 61 Asia: Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 62 Asia: Market Size, By Disease, 2013–2020 (USD Million)
Table 63 Asia: Market Size, By Technology, 2013–2020 (USD Million)
Table 64 Asia: Market Size, By End User, 2013–2020 (USD Million)
Table 65 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 66 RoW: Market Size for Consumables, By Type, 2013–2020 (USD Million)
Table 67 RoW: Tissue Diagnostics Market Size for Instruments, By Type, 2013–2020 (USD Million)
Table 68 RoW: Tissue Diagnostics Market Size, By Disease, 2013–2020 (USD Million)
Table 69 RoW: Tissue Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 70 RoW: Tissue Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 71 Market Developments Between 2012 and 2015
Table 72 New Product Launches and Product Upgrades, 2012–2015
Table 73 Acquisitions, 2012–2015
Table 74 Expansions, 2012–2015
Table 75 Agreements, Collaborations, Contracts, Marketing Initiatives, and Partnerships, 2012–2015
Table 76 Other Developments, 2012–2015

List of Figures (96 Figures)

Figure 1 Global Tissue Diagnostics Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Tissue Diagnostics Market Size, By Product, 2015 vs. 2020 (USD Million)
Figure 8 Tissue Diagnostics Market Size, By Technology, 2015 vs. 2020 (USD Million)
Figure 9 Tissue Diagnostics Market Size, By Disease, 2015 vs. 2020 (USD Million)
Figure 10 Tissue Diagnostics Market Size, By End User, 2015 vs. 2020 (USD Million)
Figure 11 Tissue Diagnostics Market Size, By Region, 2015 vs. 2020 (USD Million)
Figure 12 Rising Incidences of Cancer to Drive Market Growth
Figure 13 Immunohistochemistry Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period (2015 to 2020)
Figure 15 Asia Holds Lucrative Growth Opportunities
Figure 16 Tissue Diagnostics Market Segmentation: By Disease
Figure 17 Tissue Diagnostics Market Segmentation: By End User
Figure 18 Tissue Diagnostics Market Segmentation: By Product
Figure 19 Tissue Diagnostics Market Segmentation: By Technology
Figure 20 Increasing Incidences of Cancer are Expected to Drive the Tissue Diagnostics Market During the Forecast Period
Figure 21 Increasing Healthcare Expenditure Will Drive the Tissue Diagnostics Market
Figure 22 Rapid Growth in Healthcare Expenditure in Emerging Markets is an Important Growth Opportunity
Figure 23 Tissue Diagnostics Market, By Product
Figure 24 Tissue Diagnostics Market Size, By Product, 2015 (USD Million)
Figure 25 Tissue Diagnostics Market Size, By Consumables, 2015 (USD Million)
Figure 26 North America to Command the Largest Share of the Consumables Product Segment in 2015
Figure 27 North America to Command the Largest Share of the Antibodies Product Segment in 2015
Figure 28 North America to Command the Largest Share of the Kits Product Segment in 2015
Figure 29 North America to Command the Largest Share of the Reagents Product Segment in 2015
Figure 30 North America to Command the Largest Share of the Probes Product Segment in 2015
Figure 31 Tissue Diagnostics Market Size, By Instrument, 2015 (USD Million)
Figure 32 North America to Command the Largest Share of the Instruments Product Segment in 2015
Figure 33 North America to Command the Largest Share of the Slide-Staining Systems Product Segment in 2015
Figure 34 North America to Command the Largest Share of the Scanners Product Segment in 2015
Figure 35 North America to Command the Largest Share of the Tissue-Processing Systems Product Segment in 2015
Figure 36 North America to Command the Largest Share of the Other Instruments Product Segment in 2015
Figure 37 Tissue Diagnostics Market, By Disease
Figure 38 Tissue Diagnostics Market Size, By Disease, 2015 (USD Million)
Figure 39 North America to Command the Largest Share of the Breast Cancer Disease Segment in 2015
Figure 40 Asia to Be the Fastest-Growing Segment in the Tissue Diagnostics Market for Gastric Cancer in 2015
Figure 41 Asia to Witness Highest Growth in the Lymphoma Disease Segment in 2015
Figure 42 North America to Command the Largest Share of the Prostate Cancer Disease Segment in 2015
Figure 43 North America to Command the Largest Share of the Non-Small Cell Lung Cancer Disease Segment in 2015
Figure 44 Asia to Be the Fastest-Growing Market in the Other Diseases Segment in 2015
Figure 45 Tissue Diagnostics Market Segmentation, By Technology
Figure 46 Tissue Diagnostics Market Size, By Technology, 2015 (USD Million)
Figure 47 North America to Dominate the Immunohistochemistry Technology Segment in 2015
Figure 48 Asia to Be the Fastest-Growing Market in the in Situ Hybridization Technology Segment in 2015
Figure 49 Asia to Witness Highest Growth in the Digital Pathology and Workflow Management Technology Segment in 2015
Figure 50 North America to Dominate the Special Staining Technology Segment in 2015
Figure 51 Tissue Diagnostics Market Segmentation, By End User
Figure 52 Tissue Diagnostics Market Size, By End User, 2015 (USD Million)
Figure 53 North America to Dominate the Hospital End-User Segment in 2015
Figure 54 The Research Laboratories End-User Segment in Asia to Witness the Highest Growth in the Forecast Period
Figure 55 Pharmaceutical Companies Segment in Asia to Witness Highest Growth in the Forecast Period
Figure 56 North America to Dominate the Contract Research Organizations End-User Segment in 2015
Figure 57 North America to Dominate the Other End-Users Segment in 2015
Figure 58 Tissue Diagnostics Market Segmentation, By Region
Figure 59 North America to Dominate the Global Tissue Diagnostics Market in the Forecast Period
Figure 60 Tissue Diagnostics Market in Asia to Witness the Highest Growth From 2015 to 2020
Figure 61 North America: Market Snapshot
Figure 62 U.S. is Expected to Be the Fastest-Growing Market in North America in 2015
Figure 63 Consumables to Command the Largest Share of the Tissue Diagnostics Market in North America During the Forecast Period
Figure 64 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in North America During the Forecast Period
Figure 65 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Consumables in North America During the Forecast Period
Figure 66 Breast Cancer to Form the Largest Disease Segment in North America in 2015
Figure 67 Immunohistochemistry to Form the Largest Technology Segment in North America in 2015
Figure 68 Hospitals to Form the Largest End-User Segment in North America in 2015
Figure 69 Consumables to Command the Largest Share of the Tissue Diagnostics Market in Europe During the Forecast Period
Figure 70 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in Europe During the Forecast Period
Figure 71 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in Europe During the Forecast Period
Figure 72 Breast Cancer to Form the Largest Disease Segment in Europe in 2015
Figure 73 Immunohistochemistry to Form the Largest Technology Segment in Europe in 2015
Figure 74 Hospitals to Form the Largest End-User Segment in Europe in 2015
Figure 75 Asia: Market Snapshot
Figure 76 Consumables to Command the Largest Share of the Tissue Diagnostics Market in Asia During the Forecast Period
Figure 77 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in Asia During the Forecast Period
Figure 78 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in Asia During the Forecast Period
Figure 79 Breast Cancer to Form the Largest Disease Segment in Asia in 2015
Figure 80 Immunohistochemistry to Form the Largest Technology Segment in Asia in 2015
Figure 81 Hospitals to Form the Largest End-User Segment in Asia in 2015
Figure 82 Consumables Command the Largest Share of the Tissue Diagnostics Market in RoW During the Forecast Period
Figure 83 Antibodies to Dominate the Tissue Diagnostics Market for Consumables in RoW During the Forecast Period Between 2015–2020
Figure 84 Slide Staining Systems to Dominate the Tissue Diagnostics Market for Instruments in RoW During the Forecast Period Between 2015–2020
Figure 85 Breast Cancer to Form the Largest Disease Segment in RoW in 2015
Figure 86 Immunohistochemistry to Form the Largest Technology Segment in RoW in 2015
Figure 87 Hospitals to Form the Largest End-User Segment in RoW in 2015
Figure 88 Key Developments in the Tissue Diagnostics Market, 2010-2015
Figure 89 Tissue Diagnostics Market Share Analysis, By Key Player, 2015
Figure 90 Snapshot of the Financial Performances of the Leading Market Players
Figure 91 Abbott Laboratories, Inc.: Company Snapshot
Figure 92 Agilent Technologies, Inc.: Company Snapshot
Figure 93 Danaher Corporation: Company Snapshot
Figure 94 F. Hoffman-La Roche AG: Company Snapshot
Figure 95 Sigma-Aldrich Corporation: Company Snapshot
Figure 96 Thermo Fisher Scientific: Company Snapshot

【レポートのキーワード】

組織検査、組織検査技術、免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法、乳がん、胃がん、組織検査キット、組織検査試薬、組織検査装置、組織診断、スキャナー、医療機器、抗体

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[組織検査の世界市場:免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年08月29日現在 204,134 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆